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A modern theory of paraplegia in the treatment of
aneurysms of the thoracoabdominal aorta: An
analysis of technique specific observed/expected
ratios for paralysis
Charles W. Acher, MD, and Martha Wynn, MD, Madison, Wisc
Objective: To demonstrate that a modern theory of paraplegia prevention in thoracoabdominal aortic (TAAA) surgery is
primarily non-anatomic and derives from experimentally validated interventions that prolong the ischemic tolerance,
reduce reperfusion injury, and enhance the collateral perfusion of the spinal cord with or without assisted circulation.
Methods:Using an accurate predictive model (r2 > 0.95) for paraplegia risk we studied the effects of protective strategies
in 82 clinical series reporting more than 15,000 patients treated from 1985 to 2008. The observed/expected (O/E)
ratios were calculated for each series and the results were grouped by technique. The effect of interventions such as spinal
fluid drainage (SFD), systemic hypothermia, epidural cooling, and naloxone on O/E ratios were studied. We analyzed
changes in O/E ratios from Era 1 (1985 to 1997) to Era 2 (1997 to 2008) and within treatment techniques over time.
Results: The mean O/E ratio for paraplegia for all patients declined from 1.13 in Era 1 to 0.26 in Era 2. Adding SFD to
patients treated with assisted circulation (AC) decreased the O/E ratio from 1.03 to 0.24 (P < .0001). Adding SFD to
patients treated with aortic clamping without AC (XCL) decreased O/E from 0.91 to 0.23 (P  .0013). O/E for
hypothermic arrest (HA) declined from 0.42 to 0.14 with SFD. The addition of SFD to AC, XCL, and HA accounted for
most of the decline in O/E between Eras. Other factors which played a less defined but important role in the decline in
O/E ratios were attention to higher mean arterial pressures (MAPs), more hypothermia, and neurochemical protection.
Conclusion: Paraplegia causation is anatomic but paraplegia prevention is physiologic (non-anatomic). We demonstrate
that by using hypothermia, SFD, and increasing MAP, clinicians had similar improvements in paraplegia, reducing O/E
deficit ratios from 1.03 to as low as 0.16, with or without intercostal reimplantation, and whether or not assisted
circulation was used. Understanding the fundamental principles of paraplegia prevention and how to apply protective
strategies leads to a reduction in paralysis in clinical series with or without the use of assisted circulation. This modern
theory of paraplegia has significant implications for the rapidly advancing field of TAAA repair with branched endografts
where the same principles apply. ( J Vasc Surg 2009;49:1117-24.)Over the last 25 years, there has been a significant
decline in paraplegia risk associated with surgical repair of
the thoracoabdominal aorta. The dominate paradigm for
thinking about paraplegia causation and prevention has
remained anatomic with focus on the Artery of Adamk-
iewicz as described by Adams and van Geertruyden1 over
50 years ago. However, the major declines in paraplegia
rates have not occurred from reattaching important radic-
ular arteries but rather from the introduction of strategies
that focus on maximizing effective collateral perfusion,2
reducing cord ischemia, and increasing the ischemic toler-
ance of the spinal cord during and after aortic replacement.
What has emerged is a new paraplegia paradigm that is
anatomic in causation, but primarily non-anatomic in pre-
vention which is achieved by maximizing collateral circula-
tion and increasing the ischemic tolerance of the spinal
cord. Ironically this new paradigm has been thrown into
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doi:10.1016/j.jvs.2008.10.074sharp relief with the introduction of endovascular thoracic
aortic aneurysm (TAA) and thoracoabdominal aortic aneu-
rysm (TAAA) repair where an anatomic solution to para-
plegia prevention is not possible. It is also clear that in
endograft repair of the TAA, the more aorta covered the
greater the paraplegia risk, and paraplegia rates in endograft
repair have been reduced by applying non-anatomic strat-
egies, such as spinal fluid drainage (SFD), to prevent para-
plegia.
To study the clinical impact of protective strategies in
spinal ischemia, we derived and published a paraplegia risk
model to calculate risk index as observed/expected (O/E)
ratios for paraplegia in our own and others’ series.3 This
model was highly accurate and accounted for more than
90% of the variability in our patients and in other clinical
series. Using this model, we have previously demonstrated
that by applying the non-anatomic strategies of increased
collateral perfusion, hypothermia, SFD, and neurochemical
protection we have reduced paraplegia risk by approxi-
mately 80% to a risk index (O/E ratio) of 0.20 without
intercostal reimplantation or assisted circulation.3 More
recently we demonstrated that the addition of intercostal
reimplantation further decreased the O/E ratio to 0.05, for
a 95% reduction in paraplegia risk without assisted circula-
tion.4
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2008 and demonstrate that improved paraplegia outcomes
arise primarily from applying interventions that maximize
collateral perfusion and ischemic tolerance of the spinal
cord during aortic replacement and that these same princi-
ples apply to endovascular aneurysm repair.
MATERIALS AND METHODS
We modeled 82 clinical series reporting more than
15,000 patients spanning 25 years and calculated O/E
ratios for paraplegia for each series. We used paraplegia as a
synonym for all spinal cord-related deficits (paraparesis or
paraplegia, immediate or delayed), as we have done in all
our previous reports. Patients were classified by treatment
strategies: Crawford’s technique of cross-clamp with inter-
costal reimplantation without assisted circulation or protec-
tive adjuncts (XCL); cross-clamp without assisted circula-
tion plus SFD (XCLSFD); assisted circulation without
SFD (AC); assisted circulation with SFD (ACSFD); hy-
pothermic arrest without (HA) and with SFD (HASFD).
Our own method of SFD plus naloxone, hypothermia,
thiopental, and steroids was designated SFD/naloxone
(SFDN). We evaluated treatment strategies from 1985 to
1997 (Era 1) and from 1997 to 2008 (Era 2).
Statistical analysis. We used logistic regression and
Fisher’s Exact test to study significant variables using SAS
JMP software for analysis (SAS Institute Inc, Cary, NC).
We evaluated patients using a paraplegia predictive
model we derived and published previously. In the model,
expected deficits (0.1C1 0.2C2 0.05C3 0.02C4
0.01 TAA)  (0.3 [acute  dissection]).3 This model was
validated by evaluating several thousand patients from the
clinical literature treated without protective adjuncts and
accounted for 99% (r2  0.99) of the variability among
reports. The model compared the actual number of deficits
to the predicted number of deficits for each series and was
used to calculate O/E ratios. Deficit Risk Index (O/E
ratio)  observed/expected deficits.3 We used the predic-
tive model to study the impact of spinal cord protective
strategies reported in clinical series totaling over 15,000
patients.
RESULTS
Modeling clinical reports. We modeled 82 clinical
reports of 15,526 patients from 1985 to 2008. There was a
significant decrease in O/E ratios for paralysis over the 25
years studied (P .0001) (Fig 1). The best fit (highest r2 of
0.75) for this decline was logarithmic. We plotted expected
deficits from our predictive model vs observed deficits for
Era 1 and Era 2. The r2 for each regression line was0.97,
supporting the model’s accuracy over time. There was a
highly significant difference in mean O/E ratios between
Era 1 and Era 2 (1.13 for Era 1 vs 0.26 for Era 2, P 
.0001) (Fig 1). The predictive value of the model did not
change significantly between Era 1 and Era 2 and themodel
continued to be an excellent measure of outcomes with the
factors within themodel accounting for greater than 97% ofthe variability between series. What did change between
Era 1 and Era 2 was the O/E ratios.
We then compared reported results in the 82 series
grouped by technique of repair and Era to evaluate whether
the introduction of protective strategies accounted for the
improved results between Era 1 and Era 2 (Tables I and II).
Assisted circulation (AC). The O/E ratios for all AC
patients declined from 0.81 in Era 1 to 0.24 in Era 2 (P 
.0001). The O/E ratios for AC without adjuncts (AC No
Adj) did not change significantly between Eras (1.11 to
0.94, P  .5593) (Table I). However, when SFD was
added to AC (ACSFD) there was a significant decline in
O/E from 1.03 to 0.24 (P  .0001) (Table II). The
addition of SFD to AC clearly explains most of the decline
Fig 1. A, Plot of O/E ratios for paraplegia in clinical reports by
year shows a significant decline over the last 23 years. From the
curve of this decline we divided our analysis into Eras: Era 1 from
1985 to 1997 and Era 2 from 1997 to 2008. B, Using our
predictive model for paralysis risk we plotted observed vs estimated
(EST) deficits. The regression plots for Era 1 and 2 showed a
significant decline between Eras (P  .0001) and the model
accounted for greater than 97% of the variability between reports
for each regression line (r2  0.97).in O/E between Era 1 and Era 2 and fits with the observa-
s spin
air plu
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reports of ACSFD are in Era 2. Within the ACSFD
group there was a decline in O/E between Eras from 0.42
to 0.23 (P .1820) (Table I). The factors that account for
this decline within the same technique are less clear. In
hypothermic circulatory arrest patients (HA), the O/E
declined from 0.44 to 0.16 (P  .0257) between Eras
(Table I) and from 0.42 to 0.14 with SFD (HASFD)
(P  .0065) (Table II). The most important factor in this
decline between Eras was the introduction of SFD that
occurred in Era 2. There was not a significant change in
O/E ratios over time within AC or HA without SFD
(Table I).
NoAC. For all patients that had aortic clamping with-
out AC (XCL) the O/E ratios declined from 0.84 in Era 1
to 0.27 in Era 2 (P  .0013) (Table I). In XCL patients
Table I. Results for each technique by Era. 1  Era 1 (19
Technique C1 C2 C3 C4 TAA D
All AC1 532 555 274 172 537
All AC2 1869 2019 964 924 280
ACSFD1 111 195 115 107 4
ACSFD2 1705 1842 860 890 24
HA 1 68 72 23 9 125
HA 2 103 143 81 14 164
AC1 No Adj 353 288 136 56 408
AC2 No Adj 61 34 23 20 92
All XCL1 1071 1264 1106 1128 170
All XCL2 198 310 158 209 149
XCLSFD1 51 69 61 82 15
XCLSFD2 N/A N/A N/A N/A N/A
XCLSFDN1 38 77 32 51 36
XCLSFDN2 126 244 144 209 149
XCL1 No Adj 982 1118 1013 1041 119
XCL2 No Adj 72 66 14 0 0
AC, Assisted circulation; XCL, cross-clamp without assisted circulation; A
without assisted circulation plus spinal fluid drainage; XCLSFDN, cros
hypothermic circulatory arrest;HASFD, hypothermic circulatory arrest plu
alone.
Table II. Results and O/E ratios for each technique, all r
Technique C1 C2 C3 C4 TAA Di
AC 418 347 152 61 408
ACSFD 1797 2028 953 967 28
XCL 1054 1184 1027 1041 119
XCLSFD all 215 390 237 342 200
XCLSFD 51 69 61 82 15
XCLSFDN 164 321 176 260 185
XCLEPIDC 325 187 411 174 24
HA 73 84 27 9 146
HASFD 98 131 77 14 143
ENDO 26 1 504
ENDOSFD 23 47 67 66 253
TOTALS 3980 4419 2946 2609 1572
AC, Assisted circulation; ACSFD, assisted circulation plus spinal fluid d
without assisted circulation plus spinal fluid drainage; XCLSFDN, c
XCLEPIDC, cross-clamp without assisted circulation plus epidural coo
endograft repair without spinal fluid drainage; ENDOSFD, endograft reptreated with no protective adjuncts (XCL No Adj) O/Eratios did not change significantly between Eras (0.91 to
0.92, P  .8073) (Table I). Adding SFD to XCL signifi-
cantly decreased O/E ratios from 0.91 to 0.23 (P .0013)
(Table II). SFD clearly accounted for most of the reduction
in XCL O/Es between Eras (Table I). The O/E ratio
decreased from 0.60 for just SFD to 0.16 for SFDN (P 
.017) (Table II). Within the SFD and SFDN groups there
was no improvement over time, with risk remaining stable
for those techniques.
Protective adjuncts across techniques. When O/E
ratios for all series (Era 1 and Era 2) that used protective
adjuncts (SFD and/or hypothermia) were compared, there
was no difference in mean O/E ratios for paraplegia between
groups (P  .9942) whether it was ACSFD (O/E 
0.263), XCLSFD (O/E  0.257) or HA (HA and
HASFD) (O/E  0.255) (Fig 2). Doing this same
997) 2  Era 2 (1997-2008)
cute Exp Obsv O/E P Total %Def
4 335 246 0.81 2070 11.9
1 1102 268 0.24 .0001 6056 4.4
5 84.3 35 0.42 532 6.6
0 972.4 221 0.23 0.182 5321 4.2
6 47.8 21 0.44 297 7.1
6 96.4 15 0.16 0.0257 505 3
3 170.7 190 1.11 1241 15.3
5 34.1 32 0.94 0.5593 230 13.9
4 717 606 0.84 4736 12.8
6 218 66 0.27 0.0013 928 6.5
4 37.2 20 0.54 278 7.2
A N/A N/A N/A N/A N/A
6 48.7 8 0.16 234 3.4
9 161.5 29 0.18 0.7956 872 3.3
4 633 578 0.91 4273 13.5
7 40.4 37 0.92 0.8073 152 24.3
D, assisted circulation plus spinal fluid drainage; XCLSFD, cross-clamp
p without assisted circulation plus spinal fluid drainage/naloxone; HA,
al fluid drainage;N/A, indicates that in Era 2 no series using SCL used SFD
ts, 1985-2008
te Exp Obsv O/E Total % Def P
206.1 213 1.03 1386 15.4
1048.3 248 0.24 5773 4.3 .0001
673.3 615 0.91 4425 13.9
2447 57 0.23 1384 4.1 .0013
37.2 20 0.54 278 7.2
210.2 37 0.18 1106 3.3 .017
192.7 114 0.59 1121 10.2
53.64 23 0.42 339 6.7
90.56 13 0.143 463 2.8 .0065
22 23 1.04 531 4.3
32.15 18 0.56 456 3.9 .3174
1309 15526 8.4
e; XCL, cross-clamp without assisted circulation; XCLSFD, cross-clamp
lamp without assisted circulation plus spinal fluid drainage/naloxone;
HA, hypothermic arrest; HASFD, HAspinal fluid drainage; ENDO,
s spinal fluid drainage.85-1
is/A
46
177
10
149
9
20
26
7
111
42
5
N/
10
34
95
7
CSF
s-clamepor
s/Acu
328
1583
1031
509
54
455
394
106
196
47
53
4194
rainag
ross-c
ling;comparison just for Era 2 continued to show the groups
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creased for XCLSFD (0.26 to 0.18, P  .2432) and HA
(0.25 to 0.17, P  .1450) and remained unchanged for
ACSFD (0.26 to 0.24, P  .7422).
There were major treatment changes over time as sur-
geons adopted more effective protective strategies that
account for the improved outcomes seen in Era 2. Fewer
series in Era 2 used just AC, HA, or XCL as surgeons
transitioned to ACSFD, HASFD, and SFDN, with
most using ACSFD.Other factors changed over time that
we were not able to quantify such as increased attention to
hypothermia and perfusion pressures, fewer restrictions on
volume of spinal fluid removed so spinal fluid pressure
could be strictly controlled, and changes in neurochemical
protection.
We analyzed eight recent reports (987 patients) of
endograft treatment of TAA and TAAA. In those that used
SFD, the O/E ratio was 0.56, and in those that did not
indicate use of any protective strategies the O/E ratio was
1.04 (Table II).
DISCUSSION
Any theory should be consistent with experimental
data, real world observations, and, most of all, predictive of
future observations. What we have observed from the ex-
perimental data and our own and others’ analysis is that
factors that maximize collateral blood flow5 such as cardiac
index (CI) and mean arterial pressure (MAP) and SFD
improve spinal cord perfusion.6,7 Other interventions that
increase ischemic tolerance of the spinal cord (barbitu-
rates,8 hypothermia,9 and steroids10), reduce excitotoxicity
from neuronal ischemia (hypothermia,11 naloxone,12 and
steroids13), and attenuate reperfusion injury (steroids, hy-
Fig 2. Plot of mean O/E ratios for ACSFD, XCLSFD, and
HA (HA and HASFD) shows no difference between techniques
(P  .9942).pothermia,14 and free radical scavengers15) also reducespinal cord injury in TAAA repair. Intercostal reimplanta-
tion is not as important as these other factors, as indicated
by Greipp et al7,16 and our own reports.4,5 The most recent
report of our own results assessed the importance of inter-
costal reimplantation in a quantitative way using statistical
modeling of O/E ratios for paraplegia in patients treated
without and with intercostal reimplantation. We concluded
that non-anatomic factors accounted for 80% of paraplegia
risk and direct intercostal blood flow accounted for 20% of
risk.4
Hemodynamics. The experimental data tells us sev-
eral important things about spinal cord ischemia. The pri-
mary experimental observation is that thoracic aortic occlu-
sion causes a significant reduction in spinal cord blood flow
and perfusion pressure (80%)17 and that the negative effect
of this drop in perfusion increases with occlusion time,18
resulting in increasing risk of spinal cord infarction with
longer occlusion times. Factors that change over time with
thoracic aortic occlusion to the detriment of spinal cord
perfusion are increasing spinal fluid pressure or central
venous pressure (which decrease spinal cord perfusion pres-
sure),19,20 changes in hemodynamics such as arterial hypo-
tension,21 decreased cardiac index, and decreased oxygen
carrying capacity from blood loss. Optimizing these factors
in experimental models improves ischemic tolerance of the
cord by increasing cord perfusion and tissue oxygen deliv-
ery, thus increasing the allowable time of aortic occlusion
before irreversible ischemia and infarction occur. Increas-
ing collateral perfusion pressure increases blood flow and
relative spinal cord perfusion pressure, draining spinal fluid
decreases or prevents an increase in spinal fluid pressure
thereby increasing blood flow and relative spinal cord per-
fusion pressure, and increasing ormaintaining cardiac index
improves cord blood flow and perfusion. Aggressively cor-
recting anemia and hypovolemia and preventing coagu-
lopathy improve tissue oxygen delivery.
There is ample clinical evidence that these factors are at
play in human thoracoabdominal aortic replacement. In
our own experience SFD, MAP, and cardiac index were
important factors by univariate analysis and SFD and CI
remained significant in multivariate modeling.4 Patients
with lower CI andMAPweremore vulnerable to paraplegia
as were patients that did not have SFD. Some of the most
compelling evidence of the importance of hemodynamic
factors comes from human reports on the use of motor
evoked potentials (MEPs) to assess cord function and in-
tercostal arteries for reimplantation during aortic occlu-
sion.22 Whether clinicians believed that reattaching inter-
costals was necessary or not, both camps have shown that
increasing perfusion pressure during aortic occlusion re-
turns evoked potentials to normal in the majority of pa-
tients and that keeping MAP90 mmHg recruits enough
collateral circulation to adequately perfuse the spinal cord
during aortic occlusion.7 What our data contributes to
these observations is that collateral recruitment occurs
whether the increase in perfusion pressure is proximal (no
AC) or distal (AC) to the aortic clamp. This sameMEP data
illustrates one of the vulnerabilities of AC: the relative
JOURNAL OF VASCULAR SURGERY
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proximal collateral network. This proximal under perfusion
during AC combined with normothermic perfusion may
explain why historically the O/E ratios for AC were higher
than theO/E ratios without AC.5 Draining spinal fluid and
maintaining high perfusion pressures in this context im-
prove paraplegia outcomes significantly, as demonstrated in
the analysis of our own results. The importance of maxi-
mizing collateral hemodynamics cannot be overstated in
cord protection. We and others have shown that focusing
on enhancing collateral perfusion can protect all but the
highest risk patients from paralysis.4,7 We think some of the
improvement between Eras in the ACSFD patients dem-
onstrated in the present study is accounted for by increased
attention to these hemodynamic factors. Failure to control
hemodynamics and spinal fluid pressure may account for
less than optimal results seen in some reports, whether AC
or XCL is used in open repair or repair is endovascular.
Ischemic tolerance. Experiments have shown that the
most effective method of protecting the nervous system
from transient decreases in blood flow is hypothermia.
Hypothermia prolongs the ischemic tolerance of spinal
cord by reducing neuronal metabolism, decreasing oxygen
demand in nervous tissue,9 and reducing the levels of
neurotoxic excitatory neurotransmitters released11 during
neuronal ischemia. Profound hypothermia (15°C) is pro-
tective for the brain and spinal cord for up to 60 minutes in
aortic arch replacement. Moderate hypothermia (30 to
34°C) also significantly prolongs ischemic tolerance23 and
experimentally each degree below 36°C prolonged allow-
able ischemic time by 50%.24 These temperatures can be
accomplished without AC. Clinically, it is also apparent that
in TAAA repair using hypothermic arrest, even with exten-
sive intercostal artery reimplantation, the spinal cord is
vulnerable during rewarming as oxygen demand increases
but perfusion pressure may be low and flow is nonpulsatile.
We believe the move away from normothermia is one of the
major factors improving the results of AC or XCL when
combined with SFD seen in the present study and is a factor
in improvements between Eras for ACSFD. Not achiev-
ing significant hypothermia may also be a factor in varia-
tions seen among series using similar techniques.
Experimental studies have shown the benefit of phar-
macologic adjuncts in animal models of spinal cord isch-
emia. Thiopental has been shown to decrease nervous
tissue metabolism and protect neurons during ischemia.8
The administration of high dose steroids has also been
shown to reduce spinal cord injury in animal models of
spinal cord ischemia.10 Neurotoxicity from excitatory neu-
rotransmitter release has a less well-defined but experimen-
tally significant negative effect on ischemic tolerance of
spinal cord. Naloxone decreases this negative effect of
ischemia in animal experiments25 and has also been shown
to decrease the levels of neurotoxic excitatory neurotrans-
mitters in spinal fluid during TAAA repair in humans.12 In
our experience, the addition of naloxone to SFD had a
significant protective effect, and in the present study, O/E
ratios decreased from 0.60 in patients with SFD to 0.16 inpatients treated with SFD plus naloxone. Our attention to
hemodynamic factors, hypothermia, and controlling spinal
fluid pressure may also contribute to this difference.
Intercostal arteries. Perhaps one of the most conten-
tious and misunderstood concepts in paraplegia causation
and prevention in aortic surgery has been the role of the
intercostal arteries in spinal cord blood flow during and
after TAAA repair. Adam’s landmark paper on the anatomic
variations of spinal cord blood flow clearly defined the
anatomic paradigm of paraplegia causation and in some
ways, unfortunately, also defined the anatomic solution to
paraplegia that surgeons have focused on for decades.
However, it is now clear that although the interruption of
intercostal artery flow is causative in paraplegia, most of the
solutions for preventing paraplegia are non-anatomic, and
paraplegia prevention depends on optimizing collateral
circulation and prolonging ischemic tolerance with ‘non-
anatomic’ therapeutic interventions such as hypothermia,
SFD, optimizing hemodynamics, and neurochemical pro-
tection. This collateral circulation solution is apparent from
our own results that show an 80% reduction in paraplegia
without intercostal reimplantation or AC5 and similar re-
sults reported by Griepp et al7,16 using AC and no inter-
costal reimplantation.
The anatomic paradigm is further confused by the
observation that in TAAA patients, 50% of the intercostals
are chronically occluded26 and the anterior spinal artery is
perfused by the axial collateral network and not directly
from a greater radicular artery. Historically, attempts at
identifying and selectively reattaching the Artery of Adamk-
iewicz have had poor results with O/E ratios 1 and as
high as 4.26,27 This, along with the observation that for
many years intercostal arteries have been routinely reat-
tached by most surgeons without paralysis prevention,
highlight the failure of this strategy alone to prevent paral-
ysis.28,29 However, we have demonstrated that intercostal
artery reimplantation when added to the strategies of hy-
pothermia, SFD plus naloxone, and maximizing cardiac
function improved our O/E ratio from 0.20 to 0.04,
implying that direct intercostal blood flow accounts for 15
to 20% of the risk of paralysis in thoracoabdominal aortic
replacement.4 Although most patients have adequate col-
lateral circulation, a small number of patients do not and
these patients require intercostal reimplantation to prevent
paralysis.4
MEP data from clinical series has highlighted the im-
portance of collateral perfusion pressure in maintaining
cord function during aortic replacement whether the bias is
toward intercostal ligation or reimplantation to sustain
adequate cord perfusion. Greipp et al’s7,16 clinical reports
are especially elegant in critically evaluating the limited role
of direct intercostal blood flow for cord function during
aortic replacement and ironically are confirmed by Jacobs
et al,22 a strong advocate of selective intercostal reimplan-
tation. Both observed the effect of correcting MEPs with
higher perfusion pressures before reimplantation of inter-
costal arteries. It is clear that MEPs are overly sensitive in
paraplegia prediction. It is also clear from the MEP data
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critical for cord protection. In fact, the importance of
intercostal reimplantation may be increasing perfusion
pressure in the collateral perfusion bed rather then directly
reattaching the Artery of Adamkiewicz in the small number
of patients where it makes a critical difference.30 The recent
work of Backes et al31 usingmagnetic resonance imaging to
identify collateral circulation to the spinal cord in TAAA
patients, demonstrates the critical importance of collateral
circulation in cord protection. Unfortunately, Backes only
looked at distal collaterals, however, our own results with-
out AC suggest proximal collaterals are equally important
and the same principles of higher perfusion pressure and
increased cardiac index apply.
Assisted circulation (AC). There is no experimental
evidence that AC improves spinal cord blood flow in pri-
mates, pigs, or dogs when the experimental model simu-
lates the distal perfusion conditions during TAAA replace-
ment.17,32 If, however, the thoracic aorta is perfused below
a proximal aortic clamp in the area that gives rise to the
Greater Radicular Artery, there is some protective bene-
fit.33 Even in Meylaerts et al34 and Jacobs’ experimental
model, the controls were made hypotensive with blood loss
to demonstrate a benefit from AC.
In spite of these experimental observations, many sur-
geons believe that AC is necessary to prevent paraplegia in
TAAA repair. It is clear from our analysis that normothermic-
AC without adequate perfusion pressure, even with inter-
costal reimplantation, is not protective and AC may in-
crease paraplegia risk unless the principles of paraplegia
prevention are understood and applied. These principles
are: hypothermia is necessary to increase ischemic toler-
ance; adequate perfusion pressure is required to recruit
collateral cord perfusion; applying these concepts with SFD
reduces paraplegia risk even further; and a few patients with
the most extensive aneurysms require intercostal artery
reimplantation. So it is not the use of AC per se that makes
a difference in reducing paraplegia, but rather learning how
to use it effectively to accomplish the underlying principles
of neuroprotection and collateral recruitment that reduce
irreversible spinal cord ischemia. Critical clinical data sup-
porting this comes from the effect of MAP on MEPs from
both Griepp et al and Jacobs et al, who had comparable
improved outcomes using AC with22 and without7,16 in-
tercostal reimplantation, and our own data showing com-
parable paraplegia outcomes without AC.4 The similar
paraplegia results with or without AC illustrate that differ-
ent techniques can be used to produce the same outcomes
as long as the principles of paraplegia prevention are under-
stood and applied in an effective way. This explains the
improved outcomes using ACSFD from Era 1 to Era 2.
The theory of paraplegia prevention. What we have
learned from our own experience and analyzing the expe-
rience of others with our predictive model is that the
experimentally identified factors that optimize collateral
cord perfusion (MAP, CI, and SFD), oxygen carrying
capacity (circulating blood volume, CI, and hemoglobin),
those that increase ischemic tolerance (hypothermia, ste-roids, naloxone, and thiopental), and reduce reperfusion
injury (hypothermia and steroids) are the factors that make
the most difference when applied clinically (80% risk reduc-
tion) whether or not AC is used. It is also apparent that
direct intercostal blood flow is unnecessary in most patients
but is necessary in a small number of patients, accounting
for about 20% of overall paraplegia risk. This effect is most
important in Crawford Type 2 patients. So although the
theory of paraplegia causation is anatomic, the theory of
prevention is primarily non-anatomic.
The question remains, can we use the principles of this
theory to predict clinical observations including outcomes
for endovascular procedures where direct intercostal perfu-
sion is not possible because intercostals can not be reim-
planted? As we have shown, we can predict the effect of
current cord protection strategies and generate risk coeffi-
cients for those strategies. In the case of endovascular
treatment of thoracic and thoracoabdominal aneurysms,
there are currently just a few series to test our theory on.
Some report hybrid procedures and some report branched
or fenestrated endografts; some use protective adjuncts and
others do not. The amount of aorta covered is not precisely
defined in these reports but it is possible to extrapolate to
identify C2 and C3 equivalent coverage by description in
TAAA patients. If our theory is correct, without the use of
protective adjuncts that maximize ischemic tolerance and
collateral circulation, the O/E ratio should be around 1.0,
and if protective adjuncts are used the O/E ratio should be
no lower than 0.20 because of the effect of intercostal
exclusion.We should therefore be able to test the predictive
accuracy of our theory.
We studied eight endograft series comprising more
than 900 patients, two reporting hybrid procedures with
bypasses to the visceral vessels,35,36 three reporting
branched endografts,37-39 and three reporting just thoracic
aneurysms.40-42 In the TAAA endograft series that used
SFD prophylactically, the O/E ratio was 0.54;39-41 the
mean O/E ratio for series reporting open TAAA repair
using only SFD without hypothermia and neurochemical
protection was approximately 0.55. In endograft series
that used no protective adjuncts, the O/E ratio was
1.05.35,36,40-42 We recognize that most thoracic endovas-
cular aortic repair (TEVAR) series have low-risk patients
and those TEVAR series we included we modeled as tho-
racic aneurysms, which have a risk coefficient in the model
of 0.01. Themodel assesses the risk of the population being
studied whether it is high or low. We demonstrated, re-
gardless of whether the risk in a series is high or low, that
the risk is predictable and the series which used spinal cord
protection had predictably less paralysis than those that did
not. These O/E ratios confirm what we would predict
based on our theory and support the view that we can
understand and predict when and why we fail. These ob-
servations also support the theoretical limitations of spinal
cord protection imposed by not being able to attach inter-
costal arteries.
So we have come full circle and demonstrated that
factors affecting collateral circulation and ischemic toler-
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gia prevention whether treating TAAs with endografts or
open surgery, and in fact endografts appear to carry the
same risk of paralysis as open procedures if aortic coverage
or replacement is equivalent. In addition, paraplegia risk
conforms to the same rules in both procedures andmuch of
the variability between series comes from how effective they
have been in applying protective strategies. Understanding
these principles of spinal cord protection will improve
outcomes whether open or endograft aortic repair is done.
Our theory also opens the door for other protective mea-
sures in endograft patients such as hypothermia with cool-
ing blankets as suggested by Dr Randall Griepp, or the
experimentally demonstrated ischemic preconditioning of
the spinal cord with temporary balloon occlusion of the
aorta.43 However, the inability to reattach intercostal arter-
ies in those few patients that need direct intercostal flow
puts a theoretical limit (O/E ratio of 0.20) on paraplegia
reduction in endograft repair of TAAA, which is confirmed
by our observations to date.
In open repair, it is the application of these same
strategies that maximize collateral blood flow, reduce ner-
vous tissue oxygen demand, prolong ischemic tolerance of
the spinal cord, and reduce reperfusion injury and not the
use of AC that has reduced paralysis risk.
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The bane of thoracoabdominal aortic aneurysm repair remains
postoperative paralysis and paraplegia, including the delayed-onset
variety. Despite study and different strategies to prevent paralysis
and paraplegia, no single method of prevention has proven to be
universally applicable and effective.
Dr. Acher and his group have made an important observation;
despite recognition of the artery of Adamkiewicz as the critical
intercostal that directly supplies the spinal cord, reimplantation of
this artery, or sets of additional intercostal arteries, only makes a
marginal difference in rates of postoperative paraplegia when using
additional spinal cord protective strategies. Thus it is likely that
these other protective strategies are critical and, despite their not
providing direct spinal cord reperfusion, they provide the majority
of spinal cord protection during surgical procedures.
As such, the modern use of adjuncts that indirectly increase
spinal cord perfusion by Starling’s law (tissue perfusion  input
blood pressure – tissue back pressure) make sense. Maximizing
systolic blood pressure increases input pressure to the tissue; re-
moving spinal cord fluid reduces tissue back pressure; reducing
cord metabolic activity reduces the need for significant input
pressure.
The implications for the future in which thoracic endograftsplacement precludes revascularization of any potential critical ar-
teries, and patients with critical arteries cannot be predicted a
priori, there will be a lower limit of paralysis risk that cannot be
eliminated by endograft technology with or without the use of
spinal cord protective strategies. To minimize the risk of paralysis,
optimization of the indirect perfusion methods must be per-
formed.
The absolute degree of protection that intercostal artery reim-
plantation provides is likely to be debated in the future. The impor-
tance of intercostal reimplantation may be surgeon-dependent, with
increased importance of intercostal artery reimplantation for sur-
geons that rely on fewer additional adjuncts than used by the
authors. It also remains unclear whether the benefit of intercos-
tal artery reimplantation is limited to a specific intercostal artery,
or whether any patent intercostal artery between T8 and L1 is
sufficient.
However, it is clear that some patients may need intercostal
artery reimplantation to prevent paralysis or paraplegia, and there-
fore might benefit from open repair rather than an endovascular
approach. Identification of this subset of patients is currently
impossible. Until then, meticulous attention to details of methods
that maximize spinal cord perfusion remains critical to optimizing
results and minimizing the risk of adverse outcomes.
